Jing, Ying
Yang, Jingwen
Johnson, Douglas B. http://orcid.org/0000-0002-6390-773X
Moslehi, Javid J.
Han, Leng http://orcid.org/0000-0002-7380-2640
Article History
Accepted: 20 December 2021
First Online: 17 January 2022
Competing interests
: D.B.J. has been an advisory board member or consultant for Bristol Myers Squibb, Catalyst, Iovance, Jansen, Mallinckrodt, Merck, Mosaic ImmunoEngineering, Novartis, Oncosec, Pfizer, and Targovax and receives grant support from Bristol Myers Squibb and Incyte for work outside the scope of this article. J.J.M. has served on advisory boards for Amgen, AstraZeneca, Audentes, Boston Biomedical, Bristol Myers Squibb, Cytokinetics, Deciphera, Immuno-Core, Ipsen, Janssen, Myovant, Precigen Triple-Gene, Regeneron and Takeda. Y.J., J.Y. and L.H. declare no competing interests.